Mereo BioPharma Group plc
MREO
$2.17
-$0.08-3.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.02M | -14.62M | -12.89M | -7.05M | -15.00M |
| Total Depreciation and Amortization | -11.00K | 298.00K | 270.00K | 274.00K | 282.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -674.00K | 7.51M | 4.80M | -3.51M | 8.58M |
| Change in Net Operating Assets | 400.00K | -843.00K | -514.00K | 857.00K | -1.38M |
| Cash from Operations | -7.31M | -7.65M | -8.33M | -9.42M | -7.52M |
| Capital Expenditure | 0.00 | 0.00 | -20.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 300.00K | 0.00 | -300.00K | 0.00 | 0.00 |
| Cash from Investing | 300.00K | 0.00 | -320.00K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 487.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -134.00K | -65.00K | -40.00K | -594.00K |
| Cash from Financing | 0.00 | -134.00K | 422.00K | -40.00K | -594.00K |
| Foreign Exchange rate Adjustments | -418.00K | 1.43M | 908.00K | -1.26M | 1.20M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.43M | -6.36M | -7.32M | -10.72M | -6.91M |